Home › Funds › Kingsbury Capital Investment Advisors LLC › ALZN

Kingsbury Capital Investment Advisors LLC position in ALZN

ALZAMEND NEURO INC · Health Care

Kingsbury Capital Investment Advisors LLC reported holding 1,119,932 shares of ALZN (ALZAMEND NEURO INC) in its Q3 2026 13F filing — a position valued at US$1.9M, representing 1.83% of its reported portfolio and ranking #11 among its reported holdings. Kingsbury Capital Investment Advisors LLC has disclosed ALZN holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

Latest position (Q3 2026)1.12M sh
Reported value held$1.94M
Portfolio Weight1.83%
First reportedQ1 2026
Last changeReduce
Updated2026-10-20

Last updated: 2026-10-20 · Source: SEC EDGAR Form 13F-HR

How Kingsbury Capital Investment Advisors LLC's ALZN position evolved

Kingsbury Capital Investment Advisors LLC first disclosed a stake in ALZN in Q1 2026 at 566,733 shares (US$601K). The position peaked in Q3 2026 at 1,119,932 shares, worth US$1.9M. Across 3 filings, Kingsbury Capital Investment Advisors LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,119,932 shares valued at US$1.9M — a reduction of -209,168 shares quarter over quarter.. Notable position changes include a 135% increase in Q2 2026 (shares rose 44% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2026 566.73K $600.74K New
Q2 2026 1.33M $1.59M Add
Q3 2026 1.12M $1.94M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ALZN and 13F data

ALZN (ALZAMEND NEURO INC) is a Health Care company. 13 other funds we track also report a position in ALZN — the largest reported positions include KMT WEALTH MANAGEMENT, LLC (US$1.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ALZN

All ALZN fund holders →

FAQ

How long has Kingsbury Capital Investment Advisors LLC held ALZN?

Kingsbury Capital Investment Advisors LLC has disclosed ALZN holdings in 3 of the last 3 reported quarters, going back to Q1 2026.

What is Kingsbury Capital Investment Advisors LLC's current position in ALZN?

As of Q3 2026, Kingsbury Capital Investment Advisors LLC holds 1.12M shares of ALZN (ALZAMEND NEURO INC), valued at $1.94M, representing 1.83% of its reported portfolio and ranking #11.

Has Kingsbury Capital Investment Advisors LLC been buying or selling ALZN?

In the latest 13F filing (Q3 2026), Kingsbury Capital Investment Advisors LLC reduced its position in ALZN. The position peaked in Q3 2026 at 1.12M shares.

Which other funds hold ALZN?

Other major institutional holders of ALZN include KMT WEALTH MANAGEMENT, LLC, among 13 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.